The effect of Tulatromycin therapy of pregnant cows with genital mycoplasmosis on the morbidity and body weight of the offspring obtained from them

Abstract

In the conditions of modern development of animal husbandry, one of the important tasks is to obtain healthy viable offspring, the implementation of which is hindered by various diseases, both mothers and the young born by them. One of the little-studied diseases affecting both the health of the mother and offspring is genital mycoplasmosis. The aim of the study was to study the use of the antibiotic tulatromycin in pregnant cows with genital mycoplasmosis and its effect on the morbidity and weight gain of calves born by them. Experimental data show that the use of tulatromycin in cows with genital mycoplasmosis 40 days before delivery has a significant positive effect on the vital characteristics of their offspring. So, in comparison with calves born to cows that were not treated, the offspring from a group of cows receiving tulatromycin have a sharply reduced infection rate, there is a partial recovery of body weight and their morbidity decreases in the first month of life to the level of calves from healthy cows.